Ilepcimide: Difference between revisions

Browse history interactively ← Previous edit Next edit →Content deleted Content addedVisual WikitextInline

Revision as of 16:36, 12 February 2012 editThe chemistds (talk \| contribs)Extended confirmed users5,761 edits added CSID, (Std)InChI & (Std)InChIKey← Previous edit		Revision as of 16:46, 12 February 2012 edit undoCheMoBot (talk \| contribs)Bots141,565 edits Updating {{drugbox}} (changes to verified fields - added verified revid - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'CAS_number_Ref') per [[WP:CHEMVALID\|Chem/Drugbox valid...Next edit →
Line 1:		Line 1:
	{{Drugbox		{{Drugbox
			\| Verifiedfields = changed
	\| verifiedrevid = ~~444303212~~		\| verifiedrevid = 451225156
	\| IUPAC_name = (E)-3-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylprop-2-en-1-one		\| IUPAC_name = (E)-3-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylprop-2-en-1-one
	\| image = Ilepcimide.png		\| image = Ilepcimide.png
Line 18:		Line 19:

	<!--Identifiers-->		<!--Identifiers-->
			\| CAS_number_Ref = {{cascite\|correct\|??}}
	\| CAS_number = 23434-86-8		\| CAS_number = 23434-86-8
	\| ATC_prefix = none		\| ATC_prefix = none
Line 25:		Line 27:
	\| UNII = 5ML58O200F		\| UNII = 5ML58O200F
	\| PubChem = 641115		\| PubChem = 641115
			\| ChemSpiderID_Ref = {{chemspidercite\|changed\|chemspider}}
	\| ChemSpiderID = 556435		\| ChemSpiderID = 556435
	\| InChI = 1/C15H17NO3/c17-15(16-8-2-1-3-9-16)7-5-12-4-6-13-14(10-12)19-11-18-13/h4-7,10H,1-3,8-9,11H2/b7-5+		\| InChI = 1/C15H17NO3/c17-15(16-8-2-1-3-9-16)7-5-12-4-6-13-14(10-12)19-11-18-13/h4-7,10H,1-3,8-9,11H2/b7-5+
	\| InChIKey = BLPUOQGPBJPXRL-FNORWQNLBF		\| InChIKey = BLPUOQGPBJPXRL-FNORWQNLBF
			\| StdInChI_Ref = {{stdinchicite\|changed\|chemspider}}
	\| StdInChI = 1S/C15H17NO3/c17-15(16-8-2-1-3-9-16)7-5-12-4-6-13-14(10-12)19-11-18-13/h4-7,10H,1-3,8-9,11H2/b7-5+		\| StdInChI = 1S/C15H17NO3/c17-15(16-8-2-1-3-9-16)7-5-12-4-6-13-14(10-12)19-11-18-13/h4-7,10H,1-3,8-9,11H2/b7-5+
⚫	\| StdInChIKey = BLPUOQGPBJPXRL-FNORWQNLSA-N
			\| StdInChIKey_Ref = {{stdinchicite\|changed\|chemspider}}
		⚫	\| StdInChIKey = BLPUOQGPBJPXRL-FNORWQNLSA-N

	<!--Chemical data-->		<!--Chemical data-->

Revision as of 16:46, 12 February 2012

Pharmaceutical compound

Ilepcimide
Clinical data

ATC code	none
Identifiers
IUPAC name (E)-3-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylprop-2-en-1-one
CAS Number	23434-86-8
PubChem CID	641115
ChemSpider	556435
UNII	5ML58O200F
Chemical and physical data
Formula	C₁₅H₁₇NO₃
Molar mass	259.300 g/mol g·mol
3D model (JSmol)	Interactive image
SMILES C1CCN(CC1)C(=O)/C=C/C2=CC3=C(C=C2)OCO3
InChI InChI=1S/C15H17NO3/c17-15(16-8-2-1-3-9-16)7-5-12-4-6-13-14(10-12)19-11-18-13/h4-7,10H,1-3,8-9,11H2/b7-5+ Key:BLPUOQGPBJPXRL-FNORWQNLSA-N
(what is this?) (verify)

Ilepcimide (Antiepilepserine) is a piperidine anticonvulsant used in China.

References

Anticonvulsants (N03)

GABAergics

GABA_AR PAMs	Barbiturates: Barbexaclone Metharbital Methylphenobarbital Pentobarbital Phenobarbital Primidone; Carbamates: Cenobamate Felbamate; Benzodiazepines: Clobazam Clonazepam Clorazepate Diazepam Lorazepam Midazolam Nimetazepam Nitrazepam Temazepam; Others: Bromide (potassium bromide, sodium bromide) Imepitoin Paraldehyde Stiripentol
GABA-T inhibitors	Fatty acids (and related): Valproate Valpromide Valproate pivoxil Vigabatrin
Others	GABAR agonists: Progabide; GAT-1 inhibitors: Tiagabine

Channel
modulators

Sodium blockers	Hydantoins: Ethotoin Fosphenytoin Mephenytoin Phenytoin; Ureides: Acetylpheneturide Chlorphenacemide Phenacemide Pheneturide; Fatty acids: Valproate Valpromide Valproate pivoxil; Carboxamides: Carbamazepine Eslicarbazepine acetate Oxcarbazepine; Others: Lacosamide Lamotrigine Rufinamide Topiramate Zonisamide
Calcium blockers	Oxazolidinediones: Ethadione Paramethadione Trimethadione; Succinimides: Ethosuximide Mesuximide Phensuximide; Gabapentinoids: Gabapentin Pregabalin; Others: Imepitoin Lamotrigine Topiramate Zonisamide
Potassium openers	Retigabine

Others

CA inhibitors	Sulfonamides: Acetazolamide Ethoxzolamide Sultiame Topiramate Zonisamide
Others	Albutoin Beclamide Brivaracetam Cannabidiol Carisbamate Etiracetam Fenfluramine Ganaxolone Levetiracetam Perampanel

WHO-EM
Withdrawn from market
Clinical trials:
- Phase III
- Never to phase III

This anticonvulsant-related article is a stub. You can help Misplaced Pages by expanding it.

Categories: